| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787880 | Journal of Thoracic Oncology | 2017 | 8 Pages |
Abstract
There was no survival benefit from adjuvant CCRT compared with from platinum-based chemotherapy alone for completely resected unsuspected N2-positive NSCLC. However, the role of sequential radiotherapy administered after adjuvant chemotherapy is being evaluated, and further study is needed to evaluate the optimal radiotherapy approach for completely resected N2-positive NSCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jong-Mu MD, PhD, Jae Myung MD, PhD, Dongryul MD, PhD, Hong Kwan MD, PhD, Se-Hoon MD, PhD, Yong Soo MD, PhD, Hongryull MD, PhD, Jin Seok MD, PhD, Sin-Ho PhD, Yong Chan MD, PhD, Jhingook MD, PhD, Myung-Ju MD, PhD, Jae Ill MD, PhD, Young Mog MD, PhD,